抗发炎药市场按药物类型、用途、给药途径、分销管道和地区划分

2025 年全球抗发炎药物市场规模估计为 1,155.5 亿美元，预计到 2032 年将达到 2,100.2 亿美元，2025 年至 2032 年的复合年增长率为 8.9%。

数字。 2025 年各地区抗发炎药物市场占有率（%）

抗发炎药物是减少身体发炎的药物。它通常用于治疗涉及发炎和疼痛的病症，例如关节痛和关节炎。抗发炎药物的主要类别包括非类固醇消炎剂(NSAID)、皮质类固醇/类固醇、生物製药和白细胞介素阻断剂。非类固醇消炎剂，包括Ibuprofen和萘普生，由于其有效性和非处方性，是最常用的抗发炎药物之一。老年人口的增加、关节炎和其他发炎性疾病盛行率的上升、人们对发炎性疾病认识的提高以及新产品的推出，可能会在不久的将来推动抗发炎药物市场的成长。

市场动态：

全球抗发炎药物市场的成长受到老年人口增加、关节炎和其他发炎性疾病盛行率上升、对发炎性疾病认识的不断提高以及新产品的核准和上市等因素的推动。据估计，全球有超过3亿人患有类风湿性关节炎。由于人口老化，预计关节炎和发炎性疾病的人数将大幅增加。这可能会导致对治疗这些疾病的抗发炎药物的需求增加。然而，药物副作用、畅销药专利到期以及膳食补充剂等替代品的开发等因素可能会阻碍市场成长。新兴经济体可能为国际参与者提供扩大影响力的丰厚机会。创新製剂技术的研发以及疗效和安全性更高的生技药品的开发也可能提供新的机会。

本研究的主要特点

• 本报告对全球抗发炎药物市场进行了详细分析，并展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），以 2024 年为基准年。
• 它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球抗发炎药物市场的主要企业概况。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球抗炎药物市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球抗发炎药物市场的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球抗发炎药物市场-冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球抗发炎药物市场（按药物类型划分）（十亿美元）

• 非类固醇消炎剂(NSAlD)
• 免疫选择性抗发炎衍生物（ImSAlDs）
• 抗发炎生物製药
• 皮质类固醇

6. 2020 年至 2032 年全球抗发炎药物市场（按应用划分）（十亿美元）

• 关节炎
• 慢性阻塞性肺病(COPD)
• 多发性硬化症
• 发炎性肠道疾病(IBD)
• 痛风
• 其他的

7. 2020 年至 2032 年全球抗发炎药物市场（依给药途径划分）（十亿美元）

• 口服
• 涂层
• 注射
• 吸入

8. 2020-2032 年全球抗发炎药物市场按分销管道划分（十亿美元）

• 医院药房
• 零售药局
• 网路药局

9. 2020 年至 2032 年全球抗发炎药物市场（按地区划分）（十亿美元）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区

Global Anti-Inflammatory Drugs Market is estimated to be valued at USD 115.55 Bn in 2025 and is expected to reach USD 210.02 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032.

Figure. Anti-Inflammatory Drugs Market Share (%), By Region 2025

Anti-inflammatory drugs are medications that reduce inflammation in the body. These are commonly used to treat joint pain, arthritis, and other conditions associated with inflammation and pain. Some of the major classes of anti-inflammatory drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids/steroids, biologics, and interleukin blockers. NSAIDs including ibuprofen and naproxen are among the most commonly used anti-inflammatory medications due to their effectiveness and OTC availability. Growing geriatric population, rising prevalence of arthritis and other inflammatory diseases, increasing awareness about inflammatory conditions, and new product launches can drive the anti-inflammatory drugs market growth in the near future.

Market Dynamics:

Global anti-inflammatory drugs market growth is driven by factors such as growing geriatric population, rising prevalence of arthritis and other inflammatory diseases, increasing awareness about inflammatory conditions, new product approvals and launches. As per estimates, over 300 million people suffer from rheumatoid arthritis worldwide. The number of arthritis and inflammatory disease cases is projected to increase significantly due to aging population. This can boost demand for anti-inflammatory drugs for treatment of these diseases. However, factors such as adverse side effects of medications, patent expiries of blockbuster drugs, and development of alternatives like nutraceuticals can hamper the market growth. Emerging economies can offer lucrative opportunities for international players to expand their presence. Ongoing research on innovative formulation technologies and development of biologics with improved efficacy and safety profile can also offer new opportunities.

Key features of the study:

• This report provides in-depth analysis of the global anti-inflammatory drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global anti-inflammatory drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Abbott, Zydus Cadila, Sanofi, Merck, Roche, and Bayer
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global anti-inflammatory drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-inflammatory drugs market

Detailed Segmentation-

• By Drug Type
  • Nonsteroidal Anti-inflammatory Drugs (NSAlDs)
  • Immune Selective Anti-inflammatory Derivatives (ImSAlDs)
  • Anti-inflammatory Biologics
  • Corticosteroids
• By Application
  • Arthritis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Multiple Sclerosis
  • Inflammatory Bowel Disease (IBD)
  • Gout
  • Others
• By Route of Administration
  • Oral
  • Topical
  • Injection
  • Inhalation
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Pfizer, Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Eli Lilly and Company
  • Sanofi
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZenica PLC
  • Roche Holding AG
  • Bristol Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Gilead Sciences, Inc.
  • Horizon Therapeutics plc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Type
  • Market Snapshot, By Application
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Anti-inflammatory Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Anti-inflammatory Drugs Market, By Drug Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Nonsteroidal Anti-inflammatory Drugs (NSAlDs)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immune Selective Anti-inflammatory Derivatives (ImSAlDs)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anti-inflammatory Biologics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Corticosteroids
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Anti-inflammatory Drugs Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Obstructive Pulmonary Disease (COPD)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multiple Sclerosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammatory Bowel Disease (IBD)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gout
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Anti-inflammatory Drugs Market, By Route of Administration, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Topical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inhalation
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Anti-inflammatory Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Anti-inflammatory Drugs Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

• Company Profiles
  • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Eli Lilly and Company
  • Sanofi
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Roche Holding AG
  • Bristol Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Gilead Sciences, Inc.
  • Horizon Therapeutics plc

11. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact